Journal: Bioengineered
Article Title: U2 small nuclear RNA auxiliary factor 2, transcriptionally activated by the transcription factor Dp-1/E2F transcription factor 1 complex, enhances the growth and aerobic glycolysis of leiomyosarcoma cells
doi: 10.1080/21655979.2022.2061286
Figure Lengend Snippet: The TFDP1/E2F1 complex enhances U2AF2 transcription A . A schematic image showing the predicted binding site of TFDP1 and E2F1 in the promoter region of U2AF2 . The positions of primers used for ChIP-qPCR assay were indicated by arrows. B . QRT-PCR was conducted to detect the expression of E2F1 and TFDP1 at the mRNA level in SK-LMS-1 cells 48 h after lentiviral mediated E2F1 or TFDP1 knockdown (n = 3). C . U2AF2 expression at the mRNA level (top panel) and E2F1, TFDP1 , and U2AF2 expression at the protein level (bottom panel) in SK-LMS-1 cells 48 h after lentiviral mediated E2F1 or TFDP1 knockdown alone or in combination (n = 3). D. Relative luciferase activity of pGL3-U2AF2-promoter-WT in SK-LMS-1 cells with lentiviral mediated E2F1 or TFDP1 knockdown alone or in combination (n = 3). E-F. ChIP-qPCR assay was performed to quantify the relative enrichment of U2AF2 promoter fragments (by primer sets indicated in panel A) in the ChIP samples immunoprecipitated by anti-E2F1 or anti-TFDP1 in the lysates of SK-LMS-1 cells with E2F1 or TFDP1 knockdown alone (shE2#1 or shTF#1) or in combination (shE2#1 and shTF#1) (n = 3). G-H. K-M survival analysis was performed to explore the differences in PFS (g) and DSS (h) in leiomyosarcoma patients with high or low TFDP1 expression. * p < 0.05, ** p < 0.01, *** p < 0.001. ShE2: shE2F1, ShtTF: shTFDP1.
Article Snippet: The primary antibodies used include: anti-U2AF2 (1:1000, 15,624-1-AP, Proteintech), anti-GLUT1 (1: 2000, 66,290-1-Ig, Proteintech), anti-HK2 (1: 5000, 22,029-1-AP, Proteintech), anti-PGK1 (1: 1000, 17,811-1-AP, Proteintech), anti-PGAM1 (1: 2000, 16,126-1-AP, Proteintech), anti-TFDP1 (1:1000, sc-70,989, Santa Cruz Biotechnology, Dallas, TX, USA), anti-E2F1 (1:1000, M00257, Boster, Beijing, China). and anti-β-actin (1: 2000, 20,536-1-AP, Proteintech).
Techniques: Binding Assay, Quantitative RT-PCR, Expressing, Luciferase, Activity Assay, Immunoprecipitation